Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 30, 2013 - Issue 3
2,338
Views
140
CrossRef citations to date
0
Altmetric
APBM 2013 GUIDELINES

2013 Ambulatory Blood Pressure Monitoring Recommendations for the Diagnosis of Adult Hypertension, Assessment of Cardiovascular and other Hypertension-associated Risk, and Attainment of Therapeutic Goals

Joint Recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)

, , , , , , , , , , , , , & show all
Pages 355-410 | Received 23 Aug 2012, Accepted 01 Oct 2012, Published online: 22 Mar 2013

REFERENCES

  • Aboy M, Fernández JR, Hermida RC. (2005). Methodological considerations in the evaluation of the duration of action of antihypertenive therapy using ambulatory blood pressure monitoring. Blood Press. Monit. 10:111–115.
  • Aboy M, Fernández JR, McNames J, Hermida RC. (2006a). The individual RDH index: a novel vector index for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity. Blood Press. Monit. 11:69–78.
  • Aboy M, Fernández JR, Hermida RC. (2006b). The population RDH index. A novel vector index and graphical method for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity. Blood Press. Monit. 11:143–155.
  • Afsar B, Sezer S, Elsurer R, Ozdemir FN. (2007). Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus? Blood Press. Monit. 12:133–139.
  • Agarwal R, Andersen MJ. (2005). Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 46:514–520.
  • Agarwal R, Andersen MJ. (2006a). Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 69:1175–1180.
  • Agarwal R, Andersen MJ. (2006b). Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am. J. Nephrol. 26:503–510.
  • Agarwal R, Light RP. (2010). The effect of measuring ambulatory blood pressure on nighttime sleep and daytime activity–implications for dipping. Clin. J. Am. Soc. Nephrol. 5:281–285.
  • Agarwal R, Nissenson AR, Battle D, Coyne DW, Trout JR, Warnock DG. (2003). Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am. J. Med. 115:291–297.
  • Agarwal R, Peixoto AJ, Santos SFF, Zoccali C. (2009). Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press. Monit. 14:2–11.
  • Akaike H. (1974). A new look at the statistical model identification. IEEE Trans. Aut. Control 19:716–723.
  • Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC. (2009). Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645.
  • Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, Salvador M, Chamontin B. (2000). Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 57:2485–2491.
  • American Diabetes Association. (2012). Standards of medical care in diabetes – 2012. Diabetes Care 35 ( Suppl 1):S1–S110.
  • American National Standard. (2009). Non-invasive sphygmomanometers - Part 2: Clinical validation of automated measurement type. ANSI/AAMI/ISO 81060-2:2009. Association for the Advancement of Medical Instrumentation, Arlington, Virginia: AAMI.
  • Angeli F, Reboldi G, Verdecchia P. (2010). Masked hypertension: Evaluation, prognosis, and treatment. Am. J. Hypertens. 23:941–948.
  • Appel LJ, Wright JT Jr , Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. (2010). Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363:918–929.
  • Arima H, Barzi F, Chalmers J. (2011). Mortality patterns in hypertension. J. Hypertens. 29(suppl 1):S3–S7.
  • Asmar RG, Julia PL, Mascarel VL, Fabiani JN, Benetos A, Safar ME. (1994). Ambulatory blood pressure profile after carotid endarterectomy in patients with ischaemic arterial disease. J. Hypertens. 12:697–702.
  • Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J. Hypertens. 25:2479–2485.
  • Atalar E, Okutucu S, Aksoy H, Demiri E, Aksoyek S. (2010). Are the conventional cutoff values adequate to define hypertension in young women? Blood Press. Monit. 15:296–299.
  • Ayala DE, Hermida RC. (2001). Influence of parity and age on ambulatory monitored blood pressure during pregnancy. Hypertension 38:753–758.
  • Ayala DE, Hermida RC. (2010). Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 27:345–362.
  • Ayala DE, Hermida RC. (2013). Ambulatory blood pressure monitoring for the early identificaton of hypertension in pregnancy. Chronobiol. Int. 30: 233–259.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR, Iglesias M. (1997a). Circadian blood pressure variability in healthy and complicated pregnancies. Hypertension 30:603–610.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1997b). Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension 30:611–618.
  • Ayala DE, Hermida RC, Chayán L, Mojón A, Fontao MJ, Fernández JR. (2009). Circadian pattern of ambulatory blood pressure in untreated hypertensive patients with an without metabolic syndrome. Chronobiol. Int. 26:1189–1205.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30: 340–352.
  • Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol. Int. 30: 99–115.
  • Ayala DE, Ucieda R, Hermida RC. (2013c). Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol. Int. 30: 260–270.
  • Baguet JP, Lévy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, Mallion JM, Pépin JL. (2008). Masked hypertension in obstructive sleep apnea syndrome. J. Hypertens. 26:885–892.
  • Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC, Treating to New Targets Steering Committee and Investigators. (2010). J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur. Heart J. 31:2897–2908.
  • Bastos JM, Bertoquini S, Polonia J. (2007). Relationship of circadian blood pressure and morning blood pressure surge with the severity of metabolic syndrome in newly diagnosed hypertensives. Rev. Port. Cardiol. 26:731–741.
  • Baumgart P. (1991). Circadian rhythm of blood pressure: Internal and external triggers. Chronobiol. Int. 8:444–450.
  • Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stangoni G, Angeli G, Verdecchia P. (1999). Prognostic value of 24-hour blood pressure in pregnancy. JAMA 282:1447–1452.
  • Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241.
  • Ben-Dov IZ, Mekler J, Bursztyn M. (2008). Sex differences in ambulatory blood pressure monitoring. Am. J. Med. 121:509–514.
  • Benedetto C, Zonca M, Marozio L, Dolco C, Carandente F, Massobrio M. (1996). Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstet. Gynecol. 88:503–510.
  • Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JI, Ducimetiere P, Guize L. (1997). Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410–1415.
  • Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. (1994). Diurnal variations of blood presure and microalbuminuria in essential hypertension. Am. J. Hypertens. 7:23–29.
  • Blacher J, Gasowski J, Staessen JA, Girerd X, This L, Liu L, Wang JG, Fagard R, Safar ME. (2000). Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 160:1085–1089.
  • Bland JM, Altman DG. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307–310.
  • Bland JM, Altman DG. (1995). Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346:1085–1087.
  • Blazquez A, Martinez-Nicolas A, Salazar FJ, Rol MA, Madrid JA. (2012). Wrist skin temperature, motor activity, and body position as determinants of the circadian pattern of blood pressure. Chronobiol. Int. 29:747–756.
  • Bloch MJ, Basile JN. (2011). New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: Not ready for prime time in the United States. J. Clin. Hypertens. 13:785–786.
  • Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. (2008). Masked hypertension: a systematic review. J. Hypertens. 26:1715–1725.
  • Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219–1229.
  • Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560–567.
  • Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention. (2002). J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann. Intern. Med. 136:438–448.
  • Brickman AS, Stern N, Sowers JR. (1990). Circadian variations of catecholamines and blood pressure in patients with pseudohypoparathyroidism and hypertension. Chronobiologia 17:37–44.
  • Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92–97.
  • Brown MA, Robinson A, Bowyer L, Buddle ML, Martin A, Hargood JL, Cario GM. (1998). Ambulatory blood pressure monitoring in pregnancy: what is normal? Am. J. Obstet. Gynecol. 178:836–842.
  • Brown MA, Bowyer L, McHugh L, Davis GK, Mangos GJ, Jones M. (2001a). Twenty-four-hour automated blood pressure monitoring as a predictor of preeclampsia. Am. J. Obstet. Gynecol. 185:618–622.
  • Brown MA, Davis GK, McHugh L. (2001b). The prevalence and clinical significance of nocturnal hypertension in pregnancy. J. Hypertens. 19:1437–1444.
  • Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. (2001c). The classification and diagnosis of the hypertensive disorders of pregnancy: statement from The International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 20:ix-xiv.
  • Bur A, Herkner H, Vlcek M, Woisetschläger C, Derhaschnig U, Hirschl MM. (2002). Classification of blood pressure levels by ambulatory blood pressure in hypertension. Hypertension 40:817–822.
  • Burnham KP, Anderson DR. (2004). Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. New York: Springer-Verlag.
  • Burr ML, Dolan E, O'Brien EW, O'Brien ET, McCormack P. (2008). The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing 37:201–206.
  • Burt VL. Whelton P. Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. (1995). Prevalence of hypertension in the US adult population: results of the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305–313.
  • Cabezas-Cerrato J, Hermida RC, Cabezas-Agrícola JM, Ayala DE. (2009). Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus. Chronobiol. Int. 26:942–957.
  • Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. (2008). Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:1403–1419.
  • Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. (2008). Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Hypertens. Res. 31:865–872.
  • Cardoso CRL, Leite NC, Muxfeldt ES, Salles GF. (2012). Thresholds of ambulatory blood pressure associated with chronic complications in type 2 diabetes. Am. J. Hypertens. 25:82–88.
  • Caruana MP, Lahiri A, Cashman PM, Altman DG, Raftery EB. (1988). Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am. J. Cardiol. 62:755–759.
  • Casetta I, Granieri E, Portaluppi F, Manfredini R. (2002). Circadian variability in hemorrhagic stroke. JAMA. 287:1266–1267.
  • Catalá-López F, Sanfélix-Gimeno G, García-Torres C, Ridao M, Peiró S. (2012). Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341632 participants. J. Hypertens. 30:168–176.
  • Chau NP, Bauduceau B, Chanudet X, Larroque P, Gautier D. (1994). Ambulatory blood pressure in diabetic subjects. Am. J. Hypertens. 7:487–491.
  • Christianson, R.E. (1976). Studies on blood pressure during pregnancy. 1. Influence of parity and age. Am. J. Obstet. Gynecol. 125:509–513.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ, and the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 289:2560–2571.
  • Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348:2407–2415.
  • Coats AJ. (1996). Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials. Blood Press. Monit. 1:157–160.
  • Cockcroft JR, Wilkinson IB, Evans M, McEwan P, Peters JR, Davies S, Scanlon MF, Currie CJ. (2005). Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am. J. Hypertens. 18:1463–1467.
  • Cohen MC, Rohtla KM, Lavery CE, Muller JE, Middleman MA. (1997). Meta analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am. J. Cardiol. 79:1512–1516.
  • Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. (1992). Automatic sleep/wake identification from wrist activity. Sleep 15:461–469.
  • Cottone S, Panepinto N, Vadalà A, Zagarrigo C, Galione P, Volpe V, Cerasola G. (1995). Sympathetic overactivity and 24-hour blood pressure pattern in hypertensives with chronic renal failure. Ren. Fail. 17:751–758.
  • Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329–340.
  • Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30: 43–54.
  • Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol. Int. 30: 159–175.
  • Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F, ACCORD Study Group. (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362:1575–1585.
  • Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. (2001). High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J. Hypertens. 19:2063–2070.
  • Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. (2004a). Metabolic syndrome and target organ damage in untreated essential hypertensives. J. Hypertens. 22:1991–1998.
  • Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Sala C, Magrini F, Zanchetti A. (2004b). Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? Blood Press. 13:230–235.
  • Cuspidi C, Meani S, Valerio C, Catini E, Fusi V, Sala C, Zanchetti A. (2005). Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension. Blood Press. Monit. 10:175–180.
  • Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C, Magnaghi G, Maisaidi M, Zanchetti A. (2006). Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J. Hypertens. 24:647–653.
  • Dabrowska B, Feltynowski T, Wocial B, Szpak W, Januszewicz W. (1990). Effect of removal of phaeochromocytoma on diurnal variability of blood pressure, heart rhythm and excretion of catecholamines. J. Hum. Hypertens. 4:397–399.
  • Dart AM, Yeoh JK, Jennings GL, Cameron JD, Esmore DS. (1992). Circadian rhythms of heart rate and blood pressure after heart transplantation. J. Heart Lung Transplant. 11:784–792.
  • Davey DA, MacGillivray I. (1988). The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:892–898.
  • Davidson MB, Hix JK, Vidt DG, Brotman DJ. (2006). Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch. Intern. Med. 166:846–852.
  • de la Sierra A, del Mar Lluch M, Coca A, Aguilera MT, Sánchez M, Sierra C, Urbano-Márquez A. (1995). Assessment of salt sensitivity in essential hypertension by 24-h ambulatory blood pressure monitoring. Am. J. Hypertens. 8:970–977.
  • de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E, Pallarés V, Sarría A, Aranda P, Ruilope LM, for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. (2009). Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 53:466–472.
  • de la Sierra A, Segura J, Banegas JR, Gorostidi M, dela Cruz JJ, Armario P, Oliveras A, Ruilope LM. (2011). Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57:898–902.
  • Degaute JP, Van de Borne P, Kerkhofs M, Dramaix M, Linkowski P. (1992). Does non-invasive ambulatory blood pressure monitoring disturb sleep? J. Hypertens. 10:879–885.
  • Del Rosso G, Amoroso L, Santoferrara A, Fiederling B, Di Liberato L, Albertazzi A. (1994). Impaired blood pressure nocturnal decline and target organ damage in chronic renal failure [abstract]. J. Hypertens. 12 ( Suppl 3):S15.
  • Di Iorio A, Marini E, Lupinetti M, Zito M, Abate G. (1999). Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing 28:23–28.
  • di Rienzo M, Grassi G, Pedotti A, Mancia G. (1983). Continuous vs intermitent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 5:264–269.
  • Dixon WJ, Massey FJ. (1983). Introduction to statistical analysis. 4th edition. New York: McGraw-Hill.
  • Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161.
  • Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, O'Brien E, Staessen JA, Stanton AV. (2006). Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 47:365–370.
  • Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz J, Shimada K, Kario K. (2008). Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am. J. Hypertens. 21:443–450.
  • Enström IE, Pennert KM. (2001). 24h non-invasive ambulatory blood pressure monitoring: do the number of recordings per hour and/or ways of analyzing day and night matter? Blood Press. Monit. 6:253–256.
  • Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. (1996). Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am. J. Hypertens. 9:1139–1143.
  • Elliot H, Meredith PA. (1994). Methodological considerations in calculation of the trough:peak ratio. J. Hypertens. 12:S3–S7.
  • Elliot WJ. (1998). Circadian variation in the timing of stroke onset. A meta-analysis. Stroke 29:992–996.
  • Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. (2013). Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol. Int. 30:17–30.
  • Fagard RH. (2012). Resistant hypertension. Heart 98:254–161.
  • Fagard RH, Cornelissen VA. (2007). Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J. Hypertens. 25:2193–2198.
  • Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61.
  • Fallo F, Fanelli G, Cipolla A, Betterle C, Boscaro M, Sonino N. (1994). 24-hour blood pressure profile in Addisońs disease. Am. J. Hypertens. 7:1105–1109.
  • Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036–2045.
  • Ferguson JH, Neubauer BL, Shaar CJ. (1994). Ambulatory blood pressure monitoring during pregnancy. Establishment of standards of normalcy. Am. J. Hypertens. 7:838–843.
  • Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191–204.
  • Fernández JR, Hermida RC. (2000). Computation of model-dependent tolerance bands for ambulatorily monitored blood pressure. Chronobiol. Int. 17:567–582.
  • Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467–482.
  • Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. (1993). Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am. J. Hypertens. 6:1–7.
  • Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. (2000). Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: the Fredericia Study. Diabetes Care 23:283–289.
  • Foucan L, Deloumeaux J, Hue K, Foucan T, Blanchet-Deverly A, Meraut H, Gabriel JM, Hiesse C. (2005). High pulse pressure associated with cardiovascular events in patients with type 2 diabetes undergoing hemodialysis. Am. J. Hypertens. 18:1457–1462.
  • Frank M, Peyrard S, Bobrie G, Azizi, M. (2010). Method of mean value calculation as an additional source of variability in ambulatory blood pressure measurement. Am. J. Hypertens. 23:725–731.
  • Franklin SS, Sowers JR, Batzdorf U. (1986). Relationship between arterial blood pressure and plasma norepinephrine levels in a patient with neurogenic hypertension. Am. J. Med. 81:1105–1107.
  • Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. (1999). Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100:354–360.
  • Franz IW, Erb D, Tonnesmann U. (1992). Gestorte 24-Stunden-Blutdruckrhythmik bei normotensiven und hypertensiven Asthmatikern. Z. Kardiol. 81( Suppl 2):13–16.
  • Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
  • Giles TD, Black HR, Messerli F, White WB. (2012). Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES). J. Am. Soc. Hypertens. 6:364–366.
  • Gosse P, Lasserre R, Minifié C, Lemetayer P, Clementy J. (2004). Blood pressure on rising. J. Hypertens. 22:1113–1118.
  • Gradman AH. (2011). Sleep-time blood pressure. A validated therapeutic target. J. Am. Coll. Cardiol. 58:1174–1175.
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752.
  • Gu Q, Burt VL, Paulose-Ram R, Dillon CF. (2008). Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am. J. Hypertens. 21:789–798.
  • Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. (2003). White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J. Hum. Hypertens. 17:811–817.
  • Halberg F, Ahlgren A, Haus E. (1984). Circadian systolic and diastolic hyperbaric indices of high school and college students. Chronobiologia 11:299–309.
  • Halberg E, Delmore P, Finch M, Cornélissen G, Halberg F. (1990). Chronobiologic assessment of deviant human blood pressure: An invitation for improvements. In: Hayes DK, Pauly JE, Reiter RJ, eds. Chronobiology: Its Role in Clinical Medicine, General Biology, and Agriculture, Part A. New York: Wiley-Liss, 305–318.
  • Halligan A, O'Brien E, O'Malley K, Mee F, Atkins N, Conroy R, Walshe JJ, Darling M. (1993). Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J. Hypertens. 11:869–873.
  • Hansen TW, Kikuya M, Thijs L, Björklund-Bodegard K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Jeppesen J, Ibsen H, Imai Y, Staessen JA, IDACO Investigators. (2007). Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J. Hypertens. 25:1554–1564.
  • Hansen TW, Kikuya M, Thijs L, Li Y, Boggia J, Björklund-Bodegârd K, Torp-Pedersen C, Jeppesen J, Ibsen H, Staessen JA. (2008). Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications. J. Clin. Hypertens. (Greenwich). 10:377–381.
  • Hayashi T, Shoji T, Kitamura E, Okada N, Nakanishi I, Tsubakihara Y. (1993). Circadian blood pressure pattern in the patients with chronic glomerulonephritis. Nippon Jinzo Gakkai Shi. 35:233–237.
  • Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M, Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. (2010). Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 340:c1104.
  • Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, Mangoni AA, Cowley D, Brown MA, Ruta LA, Wilson A. (2012). Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J. Hypertens. 30:253–266.
  • Heber ME, Lahiri A, Thompson D, Raftery EB. (1989). Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin. Nephrol. 32:79–86.
  • Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137–147.
  • Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol. Int. 24:749–775.
  • Hermida RC, Ayala DE. (1997). Diagnosing gestational hypertension and preeclampsia with the 24-hour mean of blood pressure. Hypertension 30:1531–1537.
  • Hermida RC, Ayala DE. (2002). Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension 40:298–303.
  • Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619–624.
  • Hermida RC, Ayala DE. (2004). Prognostic value of ambulatory blood pressure measurements for the diagnosis of hypertension in pregnancy. Expert Rev. Cardiovasc. Ther. 2:89–105.
  • Hermida RC, Ayala DE. (2005a). Reference thresholds for 24-hour, diurnal, and nocturnal blood pressure mean values in pregnancy. Blood Press. Monit. 10:33–41.
  • Hermida RC, Ayala DE. (2005b). Circadian blood pressure variability in normotensive pregnant women as a function of parity, maternal age, and stage of gestation. Chronobiol. Int. 22:321–341.
  • Hermida RC, Ayala DE. (2009). Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: Improved blood pressure control with bedtime dosing. Hypertension 54:40–46.
  • Hermida RC, Ayala DE. (2010). Prognostic value of ambulatory blood pressure monitoring in pregnancy. J. Hypertens. 28:1110–1111.
  • Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257–266.
  • Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501–505.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (1993). Time-specified reference limits for ambulatorily monitored blood pressure in clinical health. Biomed. Instrum. Technol. 27:235–243.
  • Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267–283.
  • Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, Fernández JR. (1997a). Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 30:589–595.
  • Hermida RC, Fernández JR, Alonso I, Ayala DE, García L. (1997b). Computation of time-specified tolerance intervals for hybrid time series with nonequidistant sampling, illustrated for plasma growth hormone. Chronobiol. Int. 14:409–425.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Silva I, Ucieda R, Iglesias M. (1998). Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension 31:83–89.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesias M. (1999). Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 34:1016–1023.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Silva I, Ucieda R, Iglesias M. (2000a). Blood pressure patterns in normal pregnancy, gestational hypertension and preeclampsia. Hypertension 36:149–158.
  • Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000b). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118–125.
  • Hermida RC, Ayala DE, Iglesias M. (2001a). Predictable blood pressure variability in healthy and complicated pregnancies. Hypertension 38:736–741.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2001b). Time-qualified reference values for ambulatory blood pressure monitoring in pregnancy. Hypertension 38:746–752.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461–481.
  • Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 40:710–717.
  • Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097–1104.
  • Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: A chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183–1211.
  • Hermida RC, Ayala DE, Iglesias M. (2003a). Circadian rhythm of blood pressure challengues office values as the “gold standard” in the diagnosis of gestational hypertension. Chronobiol. Int. 20:135–156.
  • Hermida RC, Ayala DE, Iglesias M. (2003b). Administration-time dependent influence of aspirin on blood pressure in pregnant women. Hypertension 41:651–656.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR, Alonso I, Aguilar MF, Ucieda R, Iglesias M. (2003c). Differences in circadian blood pressure variability during gestation between healthy and complicated pregnancies. Am. J. Hypertens. 16:200–208.
  • Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Mojón A, López JE. (2003d). Administration-time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 42:283–290.
  • Hermida RC, Calvo C, Ayala DE, López JE, Fernández JR, Mojón A, Domínguez MJ, Covelo M. (2003e). Seasonal variation of fibrinogen in dipper and nondipper hypertensive patients. Circulation 108:1101–1106.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Iglesias M. (2004a). Reproducibility of the tolerance-hyperbaric test for diagnosing hypertension in pregnancy. J. Hypertens. 22:565–572.
  • Hermida RC, Ayala DE, Iglesias M. (2004b). Circadian blood pressure variability as a function of parity in normotensive pregnant women. J. Clin. Hypertens. 6:126–133.
  • Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004c). Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277–296.
  • Hermida RC, Fernández JR, Ayala DE, Mojón A, Alonso I, Calvo C. (2004d). Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension. Chronobiol. Int. 21:149–170.
  • Hermida RC, Ayala DE, Calvo C. (2005a). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453–459.
  • Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Fontao MJ, Soler R, Fernández JR. (2005b). Effects of the time of day of antihypertensive treatment on the ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 46:1053–1059.
  • Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007a). Chronotherapy of hypertension: Administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923–939.
  • Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007b). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715–722.
  • Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007c). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131–138.
  • Hermida RC, Ayala DE, Portaluppi F. (2007d). Circadian variation of blood pressure: The basis for the chronotherapy of hypertension. Adv. Drug Deliv. Rev. 59:904–922.
  • Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, Mojón A, Fontao MJ. Fernández JR. (2007e). Dose- and administration-time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 24:471–493.
  • Hermida RC, Ayala DE, Fernández JR, Calvo C. (2008a). Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 51:69–76.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2008b). Chronotherapy with nifedipine GITS in hypertensive patients: Improved efficacy and safety with bedtime dosing. Am. J. Hypertens. 21:948–954.
  • Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009a). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol. Int. 26:61–79.
  • Hermida RC, Chayán L, Ayala DE, Mojón A, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. (2009b). Association of metabolic syndrome and blood pressure non-dipping profile in untreated hypertension. Am. J. Hypertens. 22:307–313.
  • Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. (2010a). Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol. Int. 27:560–574.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010b). Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010c). Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am. J. Hypertens. 23:432–439.
  • Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
  • Hermida RC, Chayán L, Ayala DE, Mojón A, Fontao MJ, Fernández JR. (2011e). Relationship between metabolic syndrome, circadian time of treatment, and blood pressure non-dipping profile in essential hypertension. Chronobiol. Int. 28:509–519.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297–305.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
  • Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. (2013a). Influence of age and hypertension treatment-time on ambulatory blood presure in hypertensive patients. Chronobiol. Int. 30: 176–191.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30: 68–86.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013c). Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30: 280–314.
  • Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2013d). Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30: 55–67.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – The “normotensive non-dipper” paradox. Chronobiol. Int. 30: 87–98.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013f). Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes. Chronobiol Int. 30: 132–144.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013g). Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30: 315–327.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013h). Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30: 328–339.
  • Hermida RC, Ayala DE, Mojón A, Fontao MJ, Chayán L, Fernández JR. (2013i). Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol. Int. 30: 221–232.
  • Hermida RC, Ríos MT, Crespo JJ, Moyá A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE, on behalf on the Hygia Project Investigators. (2013j). Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension. Chronobiol. Int. 30: 192–206.
  • Higgins JR, Walshe JJ, Halligan A, O'Brien E, Conroy R, Darling MRN. (1997). Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? Br. J. Obstet. Gynaecol. 104:356–362.
  • Hornung RS, Mahler RF, Raftery EB. (1989). Ambulatory blood pressure and heart rate in diabetic patients: an assessment of autonomic function. Diabet. Med. 6:579–585.
  • Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T, Shimada K. (2003). Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am. J. Hypertens. 16:434–438.
  • Huang Y, Mai W, Hu Y, Wu Y, Song Y, Qiu R, Dong Y, Kuang J. (2011). Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension. Blood Press. Monit. 16:117–123.
  • Idema RN, van den Meiracker AH, Balk AH, Bos E, Schalekamp MA, Man in't Veld AJ. (1994a). Decreased circadian blood pressure variation up to three years after heart transplantation. Am. J. Cardiol. 73:1006–1009.
  • Idema RN, van den Meiracker AH, Balk AH, Bos E, Schalekamp MA, Man in't Veld AJ. (1994b). Abnormal diurnal variation of blood pressure, cardiac output, and vascular resistance in cardiac transplant recipients. Circulation 90:2797–2803.
  • Ikeda T, Matsubara T, Sato Y, Sakamoto N. (1993). Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J. Hypertens. 11:581–587.
  • Imai Y, Abe K, Miura Y, Nihei M, Sasaki S, Minami N, Munakata M, Taira N, Sekino H, Yamakoshi K, Yoshinaga K. (1988a). Hypertensive episodes and circadian fluctuations of blood pressure in patients with phaeochromocytoma: studies by long-term blood pressure monitoring based on a volume-oscillometric method. J. Hypertens. 6:9–15.
  • Imai Y, Abe K, Sasaki S, Minami N, Nihei M, Munakata M, Murakami O, Matsue K, Sekino H, Miura Y, Yoshinaga K. (1988b). Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 12:11–19.
  • Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Nihei M, Sekino H, Yoshinaga K. (1989). Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations. J. Hypertens. 7:113–120.
  • Imai Y, Abe K, Sasaki S, Munakata M, Minami N, Sakuma H, Hashimoto J, Yabe T, Watanabe N, Sakuma M, Yoshinaga K. (1992). Circadian blood pressure variation in patients with renovascular hypertension or primary aldosteronism. Clin. Exp. Hypertens. [A]. 14:1141–1167.
  • Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 295:2859–2866.
  • Irie K, Yamaguchi T, Minematsu K, Omae T. (1993). The J-curve phenomenon in stroke recurrence. Stroke 24:1844–1849.
  • Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689.
  • Israel S, Israel A, Ben-Dov IZ, Bursztyn M. (2011). The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Am. J. Hypertens. 24:796–801.
  • Isshiki T, Akatsuka N, Tsuneyoshi H, Oka H. (1986). Periodic fluctuation of blood pressure in a case of norepinephrine secreting extra-adrenal pheochromocytoma. Jpn. Heart J. 27:437–442.
  • James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH. (1988). The reproducibility of average, ambulatory, home, and clinical pressures. Hypertension 11:545–549.
  • JCS Joint Working Group. (2012). Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010) – Digest version. Circ. J. 76:508–519.
  • Kagan A, Faibel H, Ben-Arie G, Granevitze Z, Rapoport J. (2007). Gender differences in ambulatory blood pressure monitoring profile in obese, overweight and normal subjects. J. Hum. Hypertens. 21:128–134.
  • Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. (2008). Causes and mechanisms of nondipping hypertension. Clin. Exp. Hypertens. 30:585–597.
  • Kario K, Motai K, Mitsuhashi T, Suzuki T, Nakagawa Y, Ikeda U, Matsuo T, Nakayama T, Shimada K. (1997). Autonomic nervous dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: relation to silent cerebrovascular disease. Hypertension 30:1504–1510.
  • Kario K, Schwartz JE, Pickering TG. (1999). Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 34:685–691.
  • Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. (2001). Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38:852–857.
  • Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107:1401–1406.
  • Keenan K, Hayen A, Neal BC, Irwing L. (2009). Long term monitoring in patients receiving treatment to lower blood pressure: Analysis of data from placebo controlled randomised controlled trial. BMJ. 338:b1492.
  • Kendall DM. (2011). Blood pressure targets in diabetes: Is this the time for change. J. Clin. Hypertens. (Greenwich) 13:258–262.
  • Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. (2008). Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 51:1149–1155.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. (2012). KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2:337–414.
  • Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240–245.
  • Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. (2007). Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 115:2145–2152.
  • Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. (1998). Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J. Hypertens. 16:1545–1553.
  • Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. (2005). Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 45:602–607.
  • Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. (1992). Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am. Heart J. 123:1307–1311.
  • Kyle PM, Clark SJ, Buckley D, Kissane J, Coats AJS, De Swiet M, Redman CWG. (1993). Second trimester ambulatory blood pressure in nulliparous pregnancy: a useful screening test for pre-eclampsia?. Br. J. Obstet. Gynaecol. 100:914–919.
  • Leary AC, Donnan PT, MacDonald TM, Murphy MB. (2000). Physical activity is an independent predictor of the diurnal variation in blood pressure. J. Hypertens. 18:405–410.
  • Lee-Feldstein, A., Harburg, E., Hauenstein, L. (1980). Parity and blood pressure among four race-stress groups of females in Detroit. Am. J. Epidemiol. 111:356–366.
  • Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. (2005). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67:2089–2100.
  • Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:604–612.
  • Li C, Engström G, Hedblad B, Janzon L. (2006). Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension. J. Hypertens. 24:1523–1529.
  • Li L, Soonthornpun S, Chongsuvivatwong V. (2008). Association between circadian rhythm of blood pressure and glucose tolerance status in normotensive, non-diabetic subjects. Diabetes Res. Clin. Pract. 82:359–363.
  • Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. (1995). Left ventricular hyperthrophy in hypertension is associated with insulin-resistance metabolic syndrome. J. Hypertens. 13:433–438.
  • Lindheimer MD, Taler SJ, Cunningham FG. (2008). Hypertension in pregnancy. J. Am. Soc. Hypertens. 2:484–494.
  • Littler WA, Honour AH. (1979). Direct arterial pressure, heart rate, and electrocardiogram in unrestricted patients before and after removal of a phaeochromocytoma. Am. J. Med. 53:441–449.
  • Liu M, Takahashi H, Morita Y. (2003). Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol. Dial. Transplant. 18:563–569.
  • Lloyd-Jones DM, Evans JC, Levy D. (2005). Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294:466–472.
  • Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, Hodgkinson J, Mant J, Martin U, Williams B, Wonderling D, McManus RJ. (2011). Lancet 378:1219–1230.
  • Lugaresi E, Partinen M. (1994). Prevalence of snoring. In: Saunders NA, Sullivan CE (eds). Sleep and Breathing. New York: Marcel Dekker, 337–361.
  • Lugaresi E, Mondini S, Zucconi M, Montagna P, Cirignotta F. (1983). Staging of heavy snorers' disease: a proposal. Bull. Eur. Physiopathol. Respir. 19:590–594.
  • Mallion JM, Baguet JP, Mancia G. (2006). European Society of Hypertension Scientific Newsletter: Clinical value of ambulatory blood pressure monitoring. J. Hypertens. 24:2327–2330.
  • Mancia G, Ulian L, Parati G, Trazzi S. (1994). Increase in blood pressure reproducibility by repeated semi-automatic blood pressure measurements in the clinic environment. J. Hypertens. 12:469–473.
  • Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. (2006). Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47:846–853.
  • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007a). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
  • Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. (2007b). Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study. Daily life blood pressure, cardiac damage, and prognosis. Hypertension 49:40–47.
  • Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A. (2009). Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 27:2121–2158.
  • Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996a). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
  • Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996b). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865–868.
  • Manfredini R, Portaluppi F, Salmi R, Zamboni P, La Cecilia O, Kuwornu-Afi H, Regoli F, Bigoni M, Gallerani M. (1999a). Seasonal variation in the occurrence of non traumatic rupture of thoracic aorta. Am. J. Emerg. Med. 17:672–674.
  • Manfredini R, Portaluppi F, Zamboni P, Salmi R, Gallerani M. (1999b). Circadian variation in spontaneous rupture of abdominal aorta. Lancet 353:643–644.
  • Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555–559.
  • Manfredini R, Fabbian F, Pala M, Tiseo R, De Giorgi A, Manfredini F, Malagoni AM, Signani F, Andreati C, Boari B, Salmi R, Imberti D, Gallerani M. (2011). Seasonal and weekly patterns of occurrence of acute cardiovascular diseases: Does a gender difference exist? J. Womens Health 20:1663–1668.
  • Manfredini R, Boari B, Salmi R, Fabbian F, Pala M, Tiseo R, Portaluppi F. (2013). 24-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol. Int. 30: 6–16.
  • Mann S, Altman DG, Raftery EB, Bannister R. (1983). Circadian variation of blood pressure in autonomic failure. Circulation 68:477–483.
  • Mansoor GA, White WB, McCabe EJ, Giacco S. (2000). The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am. J. Hypertens. 13:262–267.
  • Margulies M, Voto LS, Fescina R, Lastra L, Lapidus AM, Schwarcz R. (1987). Arterial blood pressure standards during normal pregnancy and their relation with mother-fetus variables. Am. J. Obstet. Gynecol. 156:1105–1109.
  • Martinelli P, Coccagna G, Rizzuto N, Lugaresi E. (1981). Changes in systemic arterial pressure during sleep in Shy-Drager syndrome. Sleep 4:139–146.
  • Masugata H, Senda S, Goda F, Yoshihara Y, Yoshikawa K, Fujita N, Daikuhara H, Nakamura H, Taoka T, Khono M. (2006). Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens. Res. 29:897–903.
  • Matsumura K, Abe I, Fukuhara M, Kobayashi K, Sadoshima S, Hasuo K, Fujishima M. (1993). Attenuation of nocturnal BP fall in essential hypertensives with cerebral infarction [letter]. J. Hum. Hypertens. 7:309–310.
  • Meininger JC, Liehr P, Chan W, Smith G, Mueller WH. (2004). Developmental, gender, and ethnic group differences in moods and ambulatory blood pressure in adolescents. Ann. Behav. Med. 28:10–19.
  • Meredith PA. (1999). Trough:peak ratio and smoothness index for antihypertensive agents. Blood Press. Monit. 4:257–262.
  • Messerli FH, Williams B, Ritz E. (2007). Essential hypertension. Lancet 370:591–603.
  • Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2006). Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline. The Ohasama study. Hypertension 47:149–154.
  • Middeke M, Mika E, Schreiber MA, Beck B, Wächter B, Holzgreve H. (1989). Ambulante indirekte Blutdrucklangzeitmessung bei primärer und sekundärer Hypertonie Klin. Wochenschr. 67:713–716.
  • Middeke M, Kluglich M, Holzgreve H. (1991). Circadian blood pressure rhythm in primary and secondary hypertension. Chronobiol. Int. 8:451–459.
  • Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. (2011). Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch. Intern. Med. 171:1090–1098.
  • Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. (1998). Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancy. Am. J. Obstet. Gynecol. 158:393–399.
  • Mochizuki Y, Okutani M, Donfeng Y, Iwasaki H, Takusagawa M, Kohno I, Mochizuki S, Umetani K, Ishii H, Ijiri H, Komori S, Tamura K. (1998). Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am. J. Hypertens. 11:403–409.
  • Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol. Int. 30: 145–158.
  • Monteagudo PT, Nóbrega JC, Cezarini PR, Ferreira SR, Kohlmann O Jr, Ribeiro AB, Zanella MT. (1996). Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients. Eur. J. Endocrinol. 135:683–688.
  • Morgan TO. (2009). Does it matter when drugs are taken? Hypertension 54:23–24.
  • Moutquin JM, Bilodeau R, Raynault P, Amyot G, Blair JF, Labelle L, Rainville C, Gagnon L. (1982). Prospective study of arterial pressure during pregnancy. Prediction of hypertensive complications. J. Gynecol. Obstet. Biol. Reprod. (Paris) 11:833–837.
  • Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, on behalf on the Hygia Project Investigators. (2013). Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Chronobiol. Int. 30: 116–131.
  • Muller JE, Tofler GH, Stone PH. (1989). Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 79:733–743.
  • Musso NR, Vergassola C, Barone C, Lotti G. (1997). Ambulatory blood pressure monitoring: how reproducible is it? Am. J. Hypertens. 10:936–939.
  • Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. (2003). Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press. Monit. 8:181–185.
  • Myers MG, Tobe SW, McKay DW, Bolli P, Hemmelgarn BR, McAlister FA; Canadian Hypertension Education Program. (2005). New algorithm for the diagnosis of hypertension. Am. J. Hypertens. 18:1369–1374.
  • Myredal A, Friberg P, Johansson M. (2010). Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am. J. Hypertens. 23:255–259.
  • Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes 47:1501–1506.
  • Nakano S, Konishi K, Furuya K, Uehara K, Nishizawa M, Nakagawa A, Kigoshi T, Uchida K. (2005). A prognostic role of mean 24-h pulse pressure level for cardiovascular events in type 2 diabetic subjects under 60 years of age. Diabetes Care 28:95–100.
  • Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. (2012). Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens. Res. 35:750–755.
  • National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. NICE Clinical Guidelines 127: Methods, evidence and recommendations. National Clinical Guidelines Centre, London, UK. http://guidance.nice.org.uk/CG/Wave2/14.
  • National Kidney Foundation. (2002). K/DOQI clinical practice guidelines on chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 39(2 Suppl 1):S1–S266.
  • Nelson W, Cornélissen G, Hinkley D, Bingham C, Halberg F. (1983). Construction of rhythm-specified reference intervals and regions, with emphasis on ‘hybrid’ data, illustrated for plasma cortisol. Chronobiologia 10:179–193.
  • Ness RB, Kramer, RA, Flegal, KM. (1993). Gravidity, blood pressure, and hypertension among white women in the Second National Health and Nutrition Examination Survey. Epidemiology 4:303–309.
  • Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. (2004). Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109:42–46.
  • O'Brien E, Sheridan J, O'Malley K. (1988). Dippers and non-dippers. Lancet (letter) 13:397.
  • O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, Bland M, Coats A, Atkins N. (1993). An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J. Hypertens. 11:677–679.
  • O'Brien A, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. (2003). European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 21:821–848.
  • O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. (2010). European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press. Monit. 15:23–38.
  • Octavio JA, Contreras J, Amair P, Octavio B, Fabiano D, Moleiro F, Omboni S, Groppelli A, Bilo G, Mancia G, Parati G. (2010). Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures. J. Hypertens. 28:459–464.
  • Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, RakugiH Japanese Society of Hypertension Committee. (2009). The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens. Res. 32:3–107.
  • Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. (1998). Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 32:255–259.
  • Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183–2189.
  • Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring. 10-year follow-up from the Ohasama study. J. Am. Coll. Cardiol. 46:508–515.
  • Oishi S, Sasaki M, Ohno M, Umeda T, Sato T. (1988). Periodic fluctuation of blood pressure and its management in a patient with pheochromocytoma. Case report and review of the literature. Jpn. Heart J. 29:389–399.
  • Okonofua FE, Balogun JA, Amiengheme NA, O'Brien, SP. (1992). Blood pressure changes during pregnancy in Nigerian women. Int. J. Cardiol. 37:373–379.
  • Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. (2005). Effects of blood pressure levels on case fatality after acute stroke. J. Hypertens. 23:1217–1223.
  • Omboni S, Parati G, Zanchetti A, Mancia G. (1995). Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological issues. J. Hypertens. 13:1105–1112.
  • Omboni S, Parati G, Mancia G. (1998). The trough:peak ratio and the smoothness index in the evaluation of control of 24-h blood pressure by treatment in hypertension. Blood Press. Monit. 3:201–204.
  • Ong KL, Tso AW, Lam KS, Cheung BM. (2008). Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 51:1142–1148.
  • Opsahl JA, Abraham PA, Halstenson CE, Keane WF. (1988). Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-beta-D-glucosaminidase excretion in essential hypertension. Am. J. Hypertens. 1:117S–120S.
  • O'Sullivan C, Duggan J, Atkins N, O'Brien E. (2003). Twenty-four-hour ambulatory blood pressure in community-dwelling elderly men and women, aged 60-102 years. J. Hypertens. 21:1641–1647.
  • Otsuka A, Mikami H, Katahira K, Nakamoto Y, Minamitani K, Imaoka M, Nishide M, Ogihara T. (1990). Absence of nocturnal fall in blood pressure in elderly persons with Alkheimer-type dementia. J. Am. Geriatr. Soc. 38:973–978.
  • Pack AI. (1994). Obstructive sleep apnea. Adv. Intern. Med. 39:517–567.
  • Page EW, Christianson R. (1976). The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am. J. Obstet. Gynecol. 125:740–746.
  • Palaniappan L, Carnethon M, Fortman SP. (2003). Association between microalbuminuria and the metabolic syndrome: NHANES III. Am. J. Hypertens. 16:952–958.
  • Palatini P, Mos L, Santonastaso M, Saladini F, Benetti E, Mormino P, Bortolazzi A, Cozzio S. (2001). Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J. Womens. Health (Larchmt) 20:1175–1181.
  • Palmas W, Moran A, Pickering T, Eimicke JP, Teresi J, Schwartz JE, Field L, Weinstock RS, Shea S. (2006). Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 48:301–308.
  • Palmas W, Pickering T, Teresi J, Schwartz JE, Eguchi K, Field L, Weinstock RS, Shea S. (2008). Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J. Clin. Hypertens. (Greenwich) 10:12–20.
  • Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, Shea S. (2009). Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension 53:120–127.
  • Parati G, Bilo G. (2010). Evening administration of antihypertensive drugs: filling a knowledge gap. J. Hypertens. 28:1390–1392.
  • Parati G, Mutti E, Ravogli A, Trazzi S, Villani A, Mancia G. (1990). Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring. J. Hypertens. Suppl. 8:S33–S38.
  • Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. (1998). The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J. Hypertens. 16:1685–1691.
  • Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G; ESH Working Group on Blood Pressure Monitoring. (2008). European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J. Hypertens. 26:1505–1526.
  • Patterson HR. (1984). Sources of error in recording the blood pressure of patients with hypertension in general practice. BMJ 289:1661–1664.
  • Pedulla M, Silvestri R, Lasco A, Mento G, Lanuzza B, Sofia L, Frisina N. (1995). Sleep structure in essential hypertensive patients: differences between dippers and non-dippers. Blood Press. 4:232–237.
  • Peek M, Shennan A, Halligan A, Lambert PC, Taylor DJ, De Swiet M. (1996). Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome? Obstet. Gynecol. 88:1030–1033.
  • Penny JA, Halligan AWF, Shennan AH, Lambert PC, Jones DR, de Swiet M, Taylor DJ. (1998). Automated, ambulatory, or conventional blood pressure measurement in pregnancy: Which is the better predictor of severe hypertension? Am. J. Obstet. Gynecol. 178:521–526.
  • Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA. 249:2792–2798.
  • Pickering TG. (1990). The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation 81-700-702.
  • Pickering TG. (1995). White coat hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1913–1927.
  • Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. (1988). How common is white-coat hypertension? JAMA 259:225–228.
  • Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. (2005). Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. Hypertension 45:142–161.
  • Pierdomenico SD, Cuccurullo F. (2011). Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: An updated meta-analysis. Am. J. Hypertens. 24:52–58.
  • Pimenta E. Hypertension in women. (2012). Hypertens. Res. 35:148–152.
  • Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646–649.
  • Pistrosch F, Reissmann E, Wildbrett J, Koehler C, Hanefeld M. (2007). Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Am. J. Hypertens. 20:541–545.
  • Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA African American Study of Kidney Disease and Hypertension Collaborative Research Group. (2009). Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53:20–27.
  • Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940–951.
  • Portaluppi F, Smolensky MH. (2007). Circadian rhythmic and environmental determinants of 24-hour blood pressure regulation in normal and hypertensive conditions. In White WB (ed). Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Totowa, NJ: Humana Press, 135–158.
  • Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
  • Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
  • Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. (1991). Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am. J. Hypertens. 4:20–26.
  • Portaluppi F, Montanari L, Ferlini M, Vergnani L, Bagni B, degli Uberti EC. (1992a). Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur. Heart J. 13:990–996.
  • Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992b). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P. (1994a). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569–576.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994b). Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia. J. Clin. Endocrinol. Metab. 78:1075–1078.
  • Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
  • Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, Fersini C, Lugaresi E. (1997). Undiagnosed sleep-disordered breathing in male nondippers with essential hypertension. J. Hypertens. 15:1227–1233.
  • Portaluppi F, Manfredini R, Fersini C. (1999). From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events. Chronobiol. Int. 16:33–49.
  • Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
  • Portaluppi F, Cortelli P, Buonaura GC, Smolensky MH, Fabbian F. (2009). Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients? Chronobiol. Int. 26:1206–1221.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
  • Ragot S, Herpin D, Siché JP, Ingrand P, Maillon JM. (1999). Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences? J. Hypertens. 17:1805–1811.
  • Rechelhoff JF. (2001). Gender differences in the regulation of blood pressure. Hypertension 37:1199–1208.
  • Reeves RA, Shapiro AP, Thompson ME, Johnsen AM. (1986). Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 73:401–408.
  • Ridker PM, Buring JE, Cook NR, Rifai N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391–397.
  • Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, on behalf of the Hygia project Investigators. (2013). Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood presure monitoring. Chronobiol. Int. 30: 207–220.
  • Rodrigues TC, Canani LH, Viatroski RS, Hoffman LH, Esteves JF, Gross JL. (2010). Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res. Clin. Pract. 87:240–245.
  • Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. (2011). Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123:e18–e209.
  • Rosansky SJ. (1991). Nocturnal hypertension in patients receiving chronic hemodialysis [letter]. Ann. Intern. Med. 114:96.
  • Rutter MK, McComb JM, Forster J, Brady S, Marshall SM. (2000). Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet. Med. 17:321–325.
  • Sadeh A, Alster J, Urbach D, Lavie P. (1989). Actigraphically based automatic bedtime sleep-wake scoring: Validity and clinical applications. J. Ambulatory Monit. 2:209–216.
  • Safar ME, Myers MG, Leenen F, Asmar R. (2002). Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. J. Hypertens. 20:1653–1661.
  • Salles GF, Cardoso CR, Muxfeldt ES. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch. Intern. Med. 168:2340–2346.
  • Sander D, Klingelhofer J. (1993). Circadian blood pressure patterns in four cases with hemodynamic brain infarction and prolonged blood-brain barrier disturbance. Clin. Neurol. Neurosurg. 95:221–229.
  • Sander D, Klingelhöfer J. (1994). Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 25:1730–1737.
  • Sassano P, Chatellier G, Corvol P, Ménard J. (1987). Influence of observer's expectation on the placebo effect in blood pressure trials. Curr. Ther. Res. 41:305–312.
  • Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. (2003). Metabolic syndrome with and without C-reactice protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414–419.
  • Schalekamp MA, Man in‘t Veld AJ, Wenting GJ. (1985). What regulates whole body autoregulation? Clinical observations. J. Hypertens. 3:97–108.
  • Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. (2004). Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43:1817–1822.
  • Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G, Mannarino E. (2006). Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 47:881–886.
  • Schram MT, Kostense PJ, van Dijk RAJM, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CDA. (2002). Diabetes, pulse pressure and cardiovascular mortality: the Hoorn study. J. Hypertens. 20:1743–1751.
  • Sehested J, Thomas F, Thorn M, Schifter S, Regitz V, Sheikh S, Oelkers W, Palm U, Meyer-Sabellek W, Hetzer R. (1992). Level and diurnal variations of hormones of interest to the cardiovascular system in patients with heart transplants. Am. J. Cardiol. 69:397–402.
  • Sehestedt T, Hansen TW, Li Y, Richart T, Boggia J, Kikuya M, Thijs L, Stolarz-Skrzypek K, Casiglia E, Tikhonoff V, Malyutina S, Nikitin Y, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Lind L, Torp-Pedersen C, Jeppesen J, Ibsen H, Imai Y, Wang J, Sandoya E, Kawecka-Jaszcz K, Staessen JA. (2011). Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations. Hypertens. Res. 34:714–721.
  • Shimada K, Kario K. (1997). Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press. Monit. 2:333–338.
  • Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. (1990). Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 16:692–699.
  • Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. (1992). Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J. Hypertens. 10:875–878.
  • Sica DA, Wilson DK. (2000). Sodium, potassium, the sympathetic nervous system, and the renin-angiotensin system: Impact on the circadian variability in blood pressure. In: White WB, ed. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Totowa, NJ: Humana Press, 171–190.
  • Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137 p(4 Pt 2):S14–S24.
  • Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
  • Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: Basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
  • Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ (eds). Fundamentals and Applications of Controlled Release Drug Delivery. Heidelberg: Springer Verlag, 359–443.
  • Soergel M, Maisin A, Azancot-Benisty A, Loirat C. (1992). Ambulante Blutdruckmessung bei nierentransplantierten Kindern und Jugendlichen. Z. Kardiol. 81( Suppl 2):67–70.
  • Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H. (2009). Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ. J. 73:899–904.
  • Spallone V, Bernardi L, Ricordi L, Soldà P, Maiello MR, Calciati A, Gambardella S, Fratino P, Menzinger G. (1993). Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes 42:1745–1752.
  • Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, Menzinger G. (2001). Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J. Hum. Hyperten. 15:239–246.
  • Spallone V, Maiello MR, Morganti R, Mandica S, Frajese G. (2007). Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. J. Hum. Hypertens. 21:381–386.
  • Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators. (1999). Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA. 282:539–546.
  • Statius van Eps RG, van den Meiracker AH, Boomsma F, Man in't Veld AJ, Schalekamp MADH. (1994). Diurnal variation of blood pressure in patients with catecholamine-producing tumors. Am. J. Hypertens. 7:492–497.
  • Stoica E, Enulescu O. (1983). Inability to deactivate sympathetic nervous system in brainstem infarct patients. J. Neurol. Sci. 58:223–234.
  • Sturrock NDC, George E, Pound N, Stevenson J, Peck GM, Sowter H. (2000). Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet. Med. 17:360–364.
  • Suzuki Y, Kuwajima I, Kanemaru A, Shimosawa T, Hoshino S, Sakai M, Matsushita S, Ueda K, Kuramoto K. (1992). The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal change in blood pressure. J. Hypertens. 10:173–179.
  • Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA. (1995). Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. Am. J. Hypertens. 8:598–605.
  • Tamura K, Ishii H, Mukaiyama S, Halberg F. (1990). Clinical significance of ABPM over 48h rather than 24h. The Statistician 39:301–306.
  • Tartan Z, Uyarel H, Kasikcioglu H, Alper AT, Ozay B, Bilsen T, Gul M, Ozturk R, Cam N. (2006). Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J. Exp. Med. 210:57–66.
  • , Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) InvestigatorsYusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, . (2008). Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372:1174–1183.
  • Timio M, Lolli S, Verdura C, Monarca C, Merante F, Guerrini E. (1993). Circadian blood pressure changes in patients with chronic renal insufficiency: a prospective study. Ren. Fail. 15:231–237.
  • Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. (1995). “Non-dipper” hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin. Nephrol. 43:382–387.
  • Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, Mancia G, Morganti A, Pontremoli R, Trimarco B, Zanchetti A, Volpe M. (2012). Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J. Hypertens. 30:1065–1074.
  • Tohgi H, Chiba K, Kimura M. (1991). Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. Stroke 22:603–608.
  • Tominaga M, Tsuchihashi T, Kinoshita H, Abe I, Fujishima M. (1995). Disparate circadian variations of blood pressure and body temperature in bedridden elderly patients with cerebral atrophy. Am. J. Hypertens. 8:773–781.
  • Torffvit O, Agardh CD. (1993). Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. J. Intern. Med. 233:131–137.
  • Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
  • Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, Zoccali C. (2005). Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 68:1294–1302.
  • Uzu T, Kazembe FS, Ishikawa K, Nakamura S, Ikenaga T, Kimura G. (1996). High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension 28:139–142.
  • Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. (1999). Determinants of circadian blood pressure rhythm in essential hypertension. Am J. Hypertens. 12:35–39.
  • van de Borne P, Abramowicz M, Degre S, Degaute JP. (1992a). Effects of chronic congestive heart failure on 24-hour blood pressure and heart rate patterns: a hemodynamic approach. Am. Heart J. 123:998–1004.
  • van de Borne P, Leeman M, Primo G, Degaute JP. (1992b). Reappearance of a normal circadian rhythm of blood pressure after cardiac transplantation. Am. J. Cardiol. 69:794–801.
  • van de Borne P, Tielemans C, Vanherweghem JL, Degaute JP. (1992c). Effect of recombinant human erythropoietin therapy on ambulatory blood pressure and heart rate in chronic haemodialysis patients. Nephrol. Dial. Transplant. 7:45–49.
  • van de Borne P, Gelin M, Van de Stadt J, Degaute JP. (1993). Circadian rhythms of blood pressure after liver transplantation. Hypertension 21:398–405.
  • Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
  • Veglio F, Pinna G, Melchio R, Rabbia F, Molino P, Torchio C, Chiandussi L. (1993). Twenty-four-hour power spectral analysis by maximum entropy method of blood pressure in primary hyperaldosteronism. Blood Press. 2:189–196.
  • Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. (1990). Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536.
  • Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801.
  • Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. (1988). Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 32:983–988.
  • Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. (2001). Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 103:2579–2584.
  • Verdecchia P, Roboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K. (2005). Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 45:203–208.
  • Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, Ambrosio G, Reboldi G. (2012). Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 60:34–42.
  • Vriz O, Lu H, Visentin P, Nicolosi L, Mos L, Palatini P. (1997). Gender differences in the relationship between left ventricular size and ambulatory blood pressure in borderline hypertension. The HARVEST Study. Eur. Heart J. 18:664–670.
  • Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JCM, Breteler MMB. (1999). J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 34:1181–1185.
  • Vyssoulis GP, Karpanou EA, Kyvelou SMG, Adamopoulos DN, Deligeorgis AD, Spanos PG, Pietri PG, Cokkinos DF, Stefanadis CI. (2007). Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients. Blood Press. Monit. 12:351–356.
  • Waeber B, Brunner HR. (1999). Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Blood Press. 4:263–266.
  • Wang MY, Huang CJ, Chang NC, Tsai PS. (2007). Reproducibility of morning blood pressure surge and its relation to blood pressure reactivity. Clin. Exp. Hypertens. 29:357–368.
  • Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. (2006). Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation 114:2780–2787.
  • White WB, Malchoff C. (1992). Diurnal blood pressure variability in mineralocorticoid excess syndrome. Am. J. Hypertens. 5:414–418.
  • White WB, Johnson MF, Black HR, Elliot WJ, Sica DA. (2001). Gender and age affects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am. J. Hypertens. 14:1239–1247.
  • Wiegmann TB, Herron KG, Chonko AM, Mac Dougall ML, Moore WV. (1990). Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus. Diabetes 39:1556–1560.
  • Wilcox J. (1961). Observer factors in the measurement of blood pressure. Nursing Res. 10:4–17.
  • Winnicki M, Canali C, Mormino P, Palatini P; Hypertension and Ambulatory Recording Venetia Study (HARVEST) Group, Italy. (1997). Ambulatory blood pressure monitoring editing criteria. Is standardization needed? Am. J. Hypertens. 10:419–427.
  • Wizner B, Dechering DG, Thijs L, Atkins N, Fagard R, O'Brien E, de Leeuw PW, Parati G, Palatini P, Clement D, Grodzicki T, Kario K, Staessen JA. (2008). Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension. J. Hypertens. 26:1328–1335.
  • Yoshida H, Shimizu M, Ikewaki K, Taniguchi I, Tada N, Yoshimura M, Rosano G, Dahlöf B, Mochizuki S Jikei Heart Study group. (2010). Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study. J. Hypertens. 28:1150–1157.
  • Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328:1230–1235.
  • Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW, PRoFESS Study Group. (2008). Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med. 359:1225–1237.
  • Zanchetti A. (2009). Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? J. Hypertens. 27:1509–1520.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.